Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape

The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy

(2021) Patience Setordzi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma

(2021) Cui Fan et al.   Translational Oncology

Epigenetic Alteration and its Association With Downregulated FOXP3 Gene in Indian Breast Cancer Patients

(2021) Sadaf et al.   Frontiers in Genetics

Down‐regulation of EOMES drives T‐cell exhaustion via abolishing EOMES‐mediated repression of inhibitory receptors of T cells in liver cancer

(2020) Hongwei He et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

(2019) Zi-Qi Zhou et al.   Journal for ImmunoTherapy of Cancer

The Immune Landscape of Cancer

(2018) Vésteinn Thorsson et al.   IMMUNITY

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

(2018) Xiaolei Li et al.   Journal of Hematology & Oncology

Immunotherapy: Cancer immunotherapy and the value of cure

(2018) Joseph C. Del Paggio   Nature Reviews Clinical Oncology

A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer

(2018) Zhixian Liu et al.   Translational Oncology

Classification of triple-negative breast cancers based on Immunogenomic profiling

(2018) Yin He et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer

(2017) Anne-Sophie Heimes et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity

(2017) Vikram R. Juneja et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

(2017) Dung T. Le et al.   SCIENCE

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy

(2017) Teresa Davoli et al.   SCIENCE

Essential role of interferon regulatory factor 4 (IRF4) in immune cell development

(2016) Sorim Nam et al.   ARCHIVES OF PHARMACAL RESEARCH

Genomic Approaches to Understanding Response and Resistance to Immunotherapy

(2016) D. A. Braun et al.   CLINICAL CANCER RESEARCH

KEGG: new perspectives on genomes, pathways, diseases and drugs

(2016) Minoru Kanehisa et al.   NUCLEIC ACIDS RESEARCH

Role of HER2 in Brain Metastasis of Breast Cancer: a Systematic Review and Meta-Analysis

(2015) Akbar Hedayatizadeh-Omran et al.   Asian Pacific Journal of Cancer Prevention

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma

(2015) Marta Garnelo et al.   GUT

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

(2015) Timothy A. Chan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

(2015) N. A. Rizvi et al.   SCIENCE

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy

(2014) J. M. Taube et al.   CLINICAL CANCER RESEARCH

Whole genome DNA methylation signature of HER2-positive breast cancer

(2014) Breezy M Lindqvist et al.   Epigenetics

GSVA: gene set variation analysis for microarray and RNA-Seq data

(2013) Sonja Hänzelmann et al.   BMC BIOINFORMATICS

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

(2013) Gabriela Bindea et al.   IMMUNITY

Inferring tumour purity and stromal and immune cell admixture from expression data

(2013) Kosuke Yoshihara et al.   Nature Communications

Human perforin mutations and susceptibility to multiple primary cancers

(2013) Joseph A. Trapani et al.   OncoImmunology

Searching for the Achilles Heel of FOXP3

(2013) Teresa Lozano et al.   Frontiers in Oncology

Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women

(2012) Anna M. Badowska-Kozakiewicz et al.   Archives of Medical Science

Absolute quantification of somatic DNA alterations in human cancer

(2012) Scott L Carter et al.   NATURE BIOTECHNOLOGY

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

(2011) Teemu T. Junttila et al.   CANCER CELL

Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation

(2011) Tarik Möröy et al.   SEMINARS IN IMMUNOLOGY

A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer

(2011) S. Reppert et al.   Nature Communications

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

(2011) Craig H Mermel et al.   GENOME BIOLOGY

Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review

(2009) Shaheenah Dawood et al.   JOURNAL OF CLINICAL ONCOLOGY

WGCNA: an R package for weighted correlation network analysis

(2008) Peter Langfelder et al.   BMC BIOINFORMATICS

IRF4 addiction in multiple myeloma

(2008) Arthur L. Shaffer et al.   NATURE